References and Notes
1a
Römpp Lexikon Naturstoffe
Steglich W.
Fugmann B.
Lang-Fugmann S.
Thieme;
Stuttgart:
1997.
1b
Harborne JB.
Baxter H.
The Handbook of Natural Flavonoids
Vol.
1:
John Wiley and Sons;
Chichester:
1999.
1c
Beecker GR.
J. Nutr.
2003,
133:
3248S
1d
Havsteen BH.
Pharmacol. Ther.
2002,
96:
67
1e
Middleton E.
Kandaswami C.
Theoharides TC.
Pharmacol. Rev.
2000,
52:
672
2a
Daskiewies J.
Depeint F.
Viornery L.
Bayet C.
Geraldine C.
Comte G.
Gee J.
Johnson I.
Ndjoko K.
Hostettmann K.
Barron D.
J. Med. Chem.
2005,
48:
2790
2b
Rao YK.
Fang SH.
Tzeng YM.
Bioorg.
Med. Chem.
2005,
13:
6850
2c
Wang SF.
Jiang Q.
Ye YH.
Li Y.
Tan RX.
Bioorg. Med. Chem.
2005,
13:
4880
2d
Gao H.
Kawabata J.
Bioorg. Med. Chem.
2005,
13:
1661
2e
Gao GY.
Li DJ.
Keung WM.
J.
Med. Chem.
2001,
44:
3320
3a
Su B.
Hackett JC.
Diaz-Cruz ES.
Kim YW.
Brueggemeier RW.
Bioorg.
Med. Chem.
2005,
13:
6571
3b
Kim YW.
Hackett JC.
Brueggemeier RW.
J. Med. Chem.
2004,
47:
4032
3c
Traxler P.
Green J.
Mett H.
Sequin U.
Furet P.
J. Med. Chem.
1999,
42:
1018
3d
Cushman M.
Zhu H.
Geahlen RL.
Kraker AJ.
J. Med.
Chem.
1994,
37:
3353
For reviews of cross-coupling reactions
of polyhalogenated heterocycles, see:
4a
Schröter S.
Stock C.
Bach T.
Tetrahedron
2005,
61:
2245
4b
Schnürch M.
Flasik R.
Khan AF.
Spina M.
Mihovilovic MD.
Stanetty P.
Eur. J.
Org. Chem.
2006,
3283
5a
Dang TT.
Dang TT.
Ahmad R.
Reinke H.
Langer P.
Tetrahedron Lett.
2008,
49:
1698
5b
Dang TT.
Villinger A.
Langer P.
Adv. Synth. Catal.
2008,
350:
2109
5c
Hussain M.
Nguyen TH.
Langer P.
Tetrahedron
Lett.
2009,
50:
3929
5d
Tengho Toguem S.-M.
Hussain M.
Malik I.
Villinger A.
Langer P.
Tetrahedron Lett.
2009,
50:
4962
5e
Dang TT.
Dang TT.
Rasool N.
Villinger A.
Langer P.
Adv. Synth. Catal.
2009,
351:
1595
6a
Miyaura N.
Suzuki A.
Chem.
Rev.
1995,
95:
2457
6b
Miyaura N.
Top.
Curr. Chem.
2002,
219:
11
7
Nawaz M.
Ibad MF.
Obaid-Ur-Rahman A.
Khera
RA.
Villinger A.
Langer P.
Synlett
2010,
150
8a
Zembower D.
Zhang H.
J.
Org. Chem.
1998,
63:
9300
8b
Zheng X.
Meng W.
Qing F.
Tetrahedron
Lett.
2004,
45:
8083
8c
Huang X.
Tang E.
Xu WM.
Cao J.
J. Comb. Chem.
2005,
7:
802
8d
Peng W.-J.
Han X.-W.
Yu B.
Chin.
J. Chem.
2006,
24:
1154
9
Synthesis of 4-Oxo-2-phenyl-4
H
-chromene-7,8-diyl-bis(trifluoromethanesulfonate
(2)
To a CH2Cl2 solution
(10 mL) of 1 (254 mg, 1.0 mmol) was added
pyridine (0.32 mL, 4.0 mmol) at -78 ˚C under argon atmosphere.
After stirring for 10 min, Tf2O (0.40 mL, 2.4 mmol) was
added at -78 ˚C. The mixture was allowed to warm
to 0 ˚C and stirred for 4 h. The reaction mixture was filtered,
and the filtrate was concentrated in vacuo. Product 2 was
isolated by rapid column chromatography (flash silica gel, heptanes-EtOAc)
as a white solid (393 mg, 76%), mp 142-143 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 6.82
(s, 1 H), 7.43-7.52 (m, 4 H, ArH), 7.88-7.91 (m,
2 H, ArH), 8.25 (d, J = 9.4
Hz, 1 H). ¹³C NMR (75.5 MHz, CDCl3): δ = 108.3 (CH),
118.6 (q, J
F,C = 321.6
Hz, CF3), 118.7 (q, J
F,C = 320.4 Hz,
CF3), 118.9 (CH), 124.7 (C), 126.6, 126.7, 129.3 (CH), 129.9,
130.2 (C), 132.6 (CH), 143.9, 149.5, 164.5, 175.3 (C). ¹9F
NMR (282 MHz, CDCl3): δ = -72.66, -72.85.
IR (KBr): ν = 3080 (w), 1660
(s), 1613 (m), 1427 (s), 1359 (m), 1210, 1126 (s), 1053, 996, 955,
836, 794, 756 (m), 733 (w), 684 (m) cm-¹.
GC-MS (EI, 70 eV): m/z (%) = 518
(95) [M+], 385 (7), 357 (15),
321 (29), 293 (100), 219 (66), 191 (79). HRMS (EI, 70 eV): m/z calcd for C17H8F6O8S2 [M+]:
517.95700; found: 517.95651.
10
General Procedure
for Suzuki-Miyaura Cross-Coupling Reactions
A
1,4-dioxane solution (3-4 mL) of 2 (1.0
equiv), arylboronic acid 3 (1.0-1.3
equiv per desired cross-coupling reaction), K3PO4 (1.5-2.0
equiv per desired cross-coupling reaction), and Pd(PPh3)4 (5
mol%) was heated at 70-100 ˚C for 4 h.
After cooling to 20 ˚C, a sat. aq solution of
NH4Cl was added, the organic and aqueous layers were
separated, and the latter was extracted with CH2Cl2.
The combined organic layers were dried (Na2SO4),
filtered, and the filtrate was concentrated in vacuo. The residue
was purified by column chromatography.
11
2-Phenyl-7,8-di(
p
-tolyl)-4
H
-chromen-4-one (4f)
Starting with 2 (259
mg, 0.5 mmol), K3PO4 (424 mg, 2.0 mmol), Pd(PPh3)4 (5
mol%), 4-methylphenylboronic acid (3f,
177 mg, 1.3 mmol), and 1,4-dioxane (5 mL), 4f was isolated
as a crystalline light yellow solid (148 mg, 74%), mp 248-249 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 2.19
(s, 3 H, CH3), 2.29 (s, 3 H, CH3), 6.75 (s,
1 H), 6.90-7.04 (m, 8 H, ArH), 7.24-7.33 (m, 3
H, ArH), 7.39 (d, 1 H, J = 8.2
Hz, ArH), 7.48-7.51 (m, 2 H, ArH), 8.16 (d, 1 H, J = 8.2 Hz, ArH). ¹³C
NMR (75MHz, CDCl3): δ = 21.2,
21.4 (CH3), 106.7 (CH), 122.8 (C), 124.4, 126.2, 127.4,
128.6, 128.7, 128.9, 129.7 (CH), 130.2 (C), 131.0, 131.4 (CH), 131.6, 131.7,
137.0, 137.1, 146.7, 153.9, 163.2, 178.6 (C). IR (KBr): ν = 2917
(w), 1631 (m), 1592 (w), 1446, 1371 (m), 1238 (w), 1145, 1016 (m),
917 (w), 816, 773, 690 (s), 665 (m) cm-¹.
GC-MS (EI, 70 eV): m/z (%) = 402
(100) [M+], 387 (34), 359
(3), 331 (4), 299 (4), 285 (7), 243 (9), 229 (12). HRMS (EI): m/z calcd for C29H22O2 [M+]:
402.16143; found: 402.161442.
12
7-(4-Ethylphenyl)-4-oxo-2-phenyl-4
H
-chromen-8-yl Trifluoromethanesulfonate (5a)
Starting with 2 (156
mg, 0.30 mmol), K3PO4 (96 mg, 0.45 mmol),
Pd(PPh3)4 (5 mol%), (4-ethylphenyl)boronic
acid (3a, 45 mg, 0.30 mmol), and 1,4-dioxane
(3mL), 5a was isolated as a white solid
(102 mg, 72%), mp 167-168 ˚C. ¹H NMR
(500 MHz, CDCl3): δ = 1.22
(t, 3 H, J = 7.7
Hz, CH3), 2.66 (q, 2 H, J = 7.5
Hz, CH2), 6.83 (s, 1 H), 7.27 (d, 2 H, J = 8.0
Hz, ArH), 7.38 (d, 2 H, J = 8.3
Hz, ArH), 7.44 (d, 1 H, J = 8.3
Hz, ArH), 7.46-7.50 (m, 3 H, ArH), 7.95-7.97 (m, 2
H, ArH), 8.18 (d, 1 H, J = 8.3
Hz, ArH). ¹³C NMR (125.76 MHz, CDCl3): δ = 15.5
(CH3), 28.7 (CH2), 108.2 (CH), 118.0 (q, J
F,C = 320
Hz, CF3), 124.2 (C), 125.1, 126.7, 127.4, 128.3, 129.1,
129.2 (CH), 130.8, 131.6 (C), 132.1 (CH), 135.1, 140.7, 145.9, 149.0,
163.8, 176.7 (C). ¹9F NMR (282 MHz, CDCl3): δ = -74.3.
IR (KBr): ν = 2916, 2850 (w), 1622,
1568, 1447 (m), 1386 (s), 1271 (m), 1164 (s), 1041 (m), 906 (w),
811, 767, 681 (s), 634 (w) cm-¹. GC-MS
(EI, 70 eV): m/z (%) = 474
(40) [M+], 410 (28), 395 (18),
366 (3), 341 (100), 326 (8), 313 (20), 281 (4). HRMS (EI): m/z calcd for C24H17F3O5S [M+]:
474.07471; found: 474.07492.
13
8-(4-Ethylphenyl)-2-phenyl-7-(
p
-tolyl)-4
H
-chromen-4-one (6a)
Following the general procedure
starting with 5c (101 mg, 0.22 mmol), K3PO4 (93
mg, 0.44 mmol), Pd(PPh3)4 (5 mol%),
4-(ethylphenyl)boronic acid (3a, 44 mg,
0.29 mmol), and 1,4-dioxane (3 mL), 6a was
isolated as a yellow solid (60 mg, 66%), mp 198-199 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.20 (t, 3 H, J = 7.9 Hz,
CH3), 2.23 (s, 3 H, CH3), 2.62 (q, 2 H, J = 7.5 Hz),
6.79 (s, 1 H), 6.95-7.01 (m, 4 H, ArH), 7.07-7.12
(m, 4 H, ArH), 7.26-7.38 (m, 3 H, ArH), 7.43 (dd, 1 H, J = 3.4, 8.3
Hz, ArH), 7.50-7.54 (m, 2 H, ArH), 8.18 (d, 1 H, J = 8.3 Hz,
ArH). ¹³C NMR (125.75 MHz, CDCl3): δ = 15.8,
21.1 (CH3), 28.7 (CH2), 122.8 (C), 124.3,
126.2, 127.4, 128.6, 128.7, 128.8, 128.9, 129.6, 131.0, 131.3 (CH),
131.6, 131.7, 132.0, 137.0, 143.5, 146.5, 146.7, 153.9, 136.1, 178.7
(C). IR (KBr): ν = 2962, 2923, 1644
(s), 1597 (w), 1371 (m), 1202, 1096, 1016 (w), 815, 771 (m), 688
(w) cm-¹. GC-MS (EI, 70 eV): m/z (%) = 416 (100) [M+],
402 (16), 387 (49), 313 (6), 285 (14), 271 (5), 253 (6), 239 (9).
HRMS (EI): m/z calcd for C30H24O2 [M+]: 416.17783;
found: 416.17762.
14 CCDC-781627 contains all crystallographic
details of this publication and is available free of charge
at www.ccdc.cam.ac.uk/conts/retrieving.html or
can be ordered from the following address: Cambridge Crystallographic
Data Centre, 12 Union Road,
GB-Cambridge CB21EZ; fax: +44
(1223)336033; or deposit@ccdc.cam.ac.uk.
15 For a simple guide for the prediction
of the site-selectivity of palladium(0)-catalyzed cross-coupling
reactions based on the ¹H NMR chemical shift
values, see: Handy ST.
Zhang Y.
Chem. Commun.
2006,
299